Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Agnosia 2Prostatic Neoplasms 1Pain 1Neoplasms 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Fluorouracil 7Oxaliplatin 6Leucovorin 5Capecitabine 4Blood Specimen Collection 4Bevacizumab 4Pafolacianine 3Irinotecan 3Cisplatin 3Cetuximab 3pembrolizumab 2atezolizumab 2XELOX 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Paclitaxel 2IDRX-42 2Gemcitabine 2Folfox protocol 2Endoscopic Mucosal Resection 2Drug Therapy 2Docetaxel 2Carboplatin 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1sodium thiosulfate 1sodium propionate 1sacituzumab govitecan 1s-formylglutathione hydrolase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gastrointestinal Neoplasms × Anesthesia, Local × Clear all
NCT06731998 2025-09-18

LapTAP

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase NA Recruiting
48 enrolled
Gastrointestinal

Agnosia, Biliary Tract Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡